The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart.

• Status: COMPLETED
• Trial end date: 2024-04-24

Summary

Evaluate the Safety, Efficacy and Pharmacokinetics of Leuprolide Injectable Emulsion in Advanced Prostate Cancer

• Phase: PHASE3

Details

• Lead Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.